The Novo Integrated Sciences Inc (NASDAQ: NVOS) stock price soared 97.4% as of 8:42 EST following yesterday’s announcement of a joint venture with Farm 7 Group Inc., a Canadian corporation, regarding an agricultural project in Kenya.
YOUR CAPITAL IS AT RISK. 76% OF RETAIL CFD ACCOUNTS LOSE MONEY.
The company agreed to collaborate with Farm 7 Group on the project, which will see the company provide all the administration and structured finance solutions. Additionally, the JV carries an initial term of 30 years, providing for the annual distribution of net profits, with 75% allocated to Farm 7 and 25% to Novo.
Top Broker Recommendation
- eToro Top stock trading platform with 0% commission – Read our Review
- Admiral Markets More than 4500 stocks & over 200 ETFs available to invest in – Read our Review
- BlackBull 26,000+ Shares, Options, ETFs, Bonds, and other underlying assets – Read our Review
- IG Top-tier regulation – Read our Review
- XTB UK regulated by the FCA – Read our Review
YOUR CAPITAL IS AT RISK. 76% OF RETAIL CFD ACCOUNTS LOSE MONEY
The two companies will implement the Kenya Agricultural Cooperative Project, a Kenya-centric agricultural project with finalized and executed uptake contracts for food-based agricultural goods on up to 9 million hectares with potential revenue of up to $350 million.
The rally in NVOS stock witnessed today was driven by the elevated investor interest in the company, given that over 49.77 million shares had changed hands at writing. Investors were buying NVOS stock following yesterday’s announcement and the potential revenues from the JV.
Despite yesterday’s massive rally, Novo Integrated Services' market capitalisation was just below $17 million, making it a nano-cap stock. Therefore, there is a risk that unscrupulous actors could manipulate the stock.
Novo Integrated Sciences, Inc. is pioneering a holistic approach to patient-first health and wellness through a multidisciplinary healthcare ecosystem of services and product innovation. Today’s rally higher in the NVOs stock price adds to yesterday’s 63.6% rally.
The company believes that “decentralizing” healthcare through integrating medical technology and interconnectivity is an essential solution to the rapidly evolving fundamental transformation of how non-catastrophic healthcare is delivered now and in the future.
Robert Mattacchione, Novo’s CEO and Chairman, stated: “With F7 having secured guaranteed commodity buyer contracts for annual delivery of up to 1.6 million metric tons of food-based harvested commodities such as cassava starch, yellow corn, wheat, soybean, and sunflower, the project is anticipated to have significant financial impact on both organizations. Novo will be providing all administration and structured finance solutions to the joint venture.”
The Novo Integrated (NVOS) stock price.
The Novo Integrated (NVOS) stock price soared 97.4% to trade at $0.2290, from Tuesday’s closing price of $0.1160.
YOUR CAPITAL IS AT RISK. 76% OF RETAIL CFD ACCOUNTS LOSE MONEY.